Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibikase Therapeutics (IKT) Other Working Capital Changes (2020 - 2025)

Inhibikase Therapeutics (IKT) has 6 years of Other Working Capital Changes data on record, last reported at $352442.0 in Q4 2025.

  • On a quarterly basis, Other Working Capital Changes fell 42.83% to $352442.0 in Q4 2025 year-over-year; TTM through Mar 2026 was $95121.0, a 83.76% decrease, with the full-year FY2025 number at $63319.0, up 397.13% from a year prior.
  • Other Working Capital Changes reached $352442.0 in Q4 2025 per IKT's latest filing, up from -$329894.0 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for IKT hit a ceiling of $3.8 million in Q4 2021 and a floor of -$2.0 million in Q2 2021.
  • A 5-year average of $117093.6 and a median of -$61448.0 in 2024 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: crashed 6491.55% in 2021, then surged 503.75% in 2024.
  • Tracing IKT's Other Working Capital Changes over 5 years: stood at $3.8 million in 2021, then tumbled by 73.32% to $1.0 million in 2022, then plummeted by 115.17% to -$152699.0 in 2023, then soared by 503.75% to $616523.0 in 2024, then tumbled by 42.83% to $352442.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for IKT at $352442.0 in Q4 2025, -$329894.0 in Q3 2025, and $72573.0 in Q2 2025.